Victrix Computational Chemistry and Medicinal Chemistry Consultancy
Contact us
  • Home
  • Philosophy
  • Services
  • Our Clients
  • Contact
  • About
    • Press Releases
  • Victrix Sounds Off
  • Blog

The Incretin Pathway: Threat or Menace?

3/25/2013

0 Comments

 
Picture
A recent paper in the Journal of the American Medical Society has taken a look at insurance company data and found a link between people who take drugs that target this pathway and hospitalizations for pancreatitis. In general this is not good.  The endocrine society has countered taking a dim view of the statistics in the paper.  

There are two classes of drugs that target this pathway.  The GLP-1 like peptides, and the DPP4 inhibitors.  There already have been concerns with respect to cardiovascular effects of these drugs, so one more piece of bad news is a problem.  For what its worth, my gut feeling is that it's a sampling error in the statistics.  We are looking at a weak signal and humans being, the variable large omnivorous mammals that we are, require larger sample sizes to really compute meaningful result.  If you look at the pre-selection criteria, these people were already quite ill with the host of complaints that plague those with diabetes. I would wait for more information before panic

0 Comments

    Adam Kallel Ph. D.

    Our CSO sounds off about drug discovery, computational chemistry and history

    Archives

    March 2014
    January 2014
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013

    Categories

    All
    Ageing
    Amphetamine
    Anti-virals
    Biography
    Broken Society
    Caffeine
    Cancer
    Cd26
    Cluster Headache
    Colic
    Collaboration
    Corona Virus
    Danger Danger
    Depression
    Drug Discovery
    Drug Resistence
    Economy Of Scale
    Electron Microscopy
    Emergent Infectious Disease
    Encephalitis Lethargica
    Global Epidemiology
    Goal Setting
    HCoV-EMC
    Hiring
    Incorrect Pathologizing
    Incretin
    Influenza
    Jobs
    Me
    Merck
    Mergers
    Metabolic Disease
    Migraine
    Nerd
    Neurotransmiters
    Open Positions
    Over Prescription
    Overwork
    Pharma
    Pharmaceutical Industry
    Restructuring
    Stimulants
    Telomerase
    Tuberculosis
    Viral Replication
    Virus

    RSS Feed

    comments powered by Disqus
    View my profile on LinkedIn